International Journal of Radiation Oncology * Biology * Physics
Volume 77, Issue 4 , Pages 1240-1247 , 15 July 2010

Stability, Visibility, and Histologic Analysis of a New Implanted Fiducial for Use as a Kilovoltage Radiographic or Radioactive Marker for Patient Positioning and Monitoring in Radiotherapy

Presented in part at the 50th Annual Meeting of the American Association of Physicists in Medicine, July 27–31, 2008, Houston, TX.

  • David Neustadter, Ph.D.

      Affiliations

    • Navotek Medical Ltd., Yokneam, Israel
    • Corresponding Author InformationReprint requests to: David Neustadter, P.O.B. 201, Yokneam 20692, Israel. Tel: (+972) 72-270-9020; Fax: (+972) 72-270-9021
  • ,
  • Michal Tune, B.S.

      Affiliations

    • Navotek Medical Ltd., Yokneam, Israel
  • ,
  • Asaph Zaretsky, D.V.M.

      Affiliations

    • Technion Israel Institute of Technology, Haifa, Israel
  • ,
  • Rona Shofti, Ph.D.

      Affiliations

    • Technion Israel Institute of Technology, Haifa, Israel
  • ,
  • Arnon Kushnir, D.V.M.
  • ,
  • Tami Harel, Ph.D.

      Affiliations

    • Navotek Medical Ltd., Yokneam, Israel
  • ,
  • Dafna Carmi-Yinon, M.D.

      Affiliations

    • Navotek Medical Ltd., Yokneam, Israel
  • ,
  • Ben Corn, M.S.

      Affiliations

    • Tel Aviv Medical Center, Tel Aviv, Israel

Received 15 June 2009 ,Revised 24 September 2009 ,Accepted 24 September 2009.

References 

  1. Zelefsky MJ, Levin EJ, Hunt M, et al. Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys. 2008;70:1124–1129
  2. Greer PB, Dahl K, Ebert MA, et al. Comparison of prostate set-up accuracy and margins with off-line bony anatomy corrections and online implanted fiducial-based corrections. J Med Imaging Radiat Oncol. 2008;52:511–516
  3. Litzenberg DW, Balter JM, Hadley SW, et al. Influence of intrafraction motion on margins for prostate radiotherapy. Int J Radiat Oncol Biol Phys. 2006;65:548–553
  4. Moseley DJ, White EA, Wiltshire KL, et al. Comparison of localization performance with implanted fiducial markers and cone-beam computed tomography for on-line image-guided radiotherapy of the prostate. Int J Radiat Oncol Biol Phys. 2007;67:942–953
  5. Owen R, Kron T, Foroudi F, et al. The detectability and localization accuracy of implanted fiducial markers determined on in-room computerized tomography (CT) and electronic portal images (EPI). Med Dosim. 2008;33:226–233
  6. Gates L, Gladstone D, Kasibhatla M, et al. Prostate localization using serrated gold coil markers. Int J Radiat Oncol Biol Phys. 2007;69:S382
  7. Kupelian P, Willoughby T, Mahadevan A, et al. Multi-institutional clinical experience with the calypso system in localization and continuous, real-time monitoring of the prostate gland during external radiotherapy. Int J Radiat Oncol Biol Phys. 2007;67:1088–1098
  8. Djemil T, Schifter D, Mahadevan A, et al. Accuracy and consistency in the identification of a novel non-migrating fiducial marker in CT images. Int J Radiat Oncol Biol Phys. 2008;72:S578–S579
  9. Willoughby T, Balter JM, Pouliot J, et al. The accuracy of Beacon™ transponder coordinate capture from CT images. Abstract presented at the 46th Annual Meeting of the American Association of Physicists in Medicine. July 25–29, 2004, Pittsburgh, PA.
  10. Aubin S, Beaulieu L, Pouliot S, et al. Robustness and precision of an automatic marker detection algorithm for online prostate daily targeting using a standard V-EPID. Med Phys. 2003;30:1825–1832
  11. Dehnad H, Nederveen AJ, van der Heide UA, et al. Clinical feasibility study for the use of implanted gold seeds in the prostate as reliable positioning markers during megavoltage irradiation. Radiother Oncol. 2003;67:295–302
  12. Kupelian PA, Willoughby TR, Meeks SL, et al. Intraprostatic fiducials for localization of the prostate gland: Monitoring intermarker distances during radiation therapy to test for marker stability. Int J Radiat Oncol Biol Phys. 2005;62:1291–1296
  13. Poggi MM, Gant DA, Sewchand W, et al. Marker seed migration in prostate localization. Int J Radiat Oncol Biol Phys. 2003;56:1248–1251
  14. Litzenberg D, Dawson LA, Sandler H, et al. Daily prostate targeting using implanted radiopaque markers. Int J Radiat Oncol Biol Phys. 2002;52:699–703
  15. Pouliot J, Aubin M, Langen KM, et al. (Non)-migration of radiopaque markers used for on-line localization of the prostate with an electronic portal imaging device. Int J Radiat Oncol Biol Phys. 2003;56:862–866
  16. Willoughby TR, Kupelian PA, Pouliot J, et al. Target localization and real-time tracking using the Calypso 4D localization system in patients with localized prostate cancer. Int J Radiat Oncol Biol Phys. 2006;65:528–534
  17. Schallenkamp JM, Herman MG, Kruse JJ, et al. Prostate position relative to pelvic bony anatomy based on intraprostatic gold markers and electronic portal imaging. Int J Radiat Oncol Biol Phys. 2005;63:800–811
  18. Schiffner DC, Gottschalk AR, Lometti M, et al. Daily electronic portal imaging of implanted gold seed fiducials in patients undergoing radiotherapy after radical prostatectomy. Int J Radiat Oncol Biol Phys. 2007;67:610–619
  19. Langenhuijsen JF, van Lin EN, Kiemeney LA, et al. Ultrasound-guided transrectal implantation of gold markers for prostate localization during external beam radiotherapy: Complication rate and risk factors. Int J Radiat Oncol Biol Phys. 2007;69:671–676
  20. van Herk M, Remeijer P, Lebesque JV. Inclusion of geometric uncertainties in treatment plan evaluation. Int J Radiat Oncol Biol Phys. 2002;52:1407–1422
  21. Jin L, Ma C, Xu Q, et al. Geometrical uncertainty caused by prostate rotation during radiotherapy. Med Phys. 2008;35:2701–2702
  22. Aubry JO, Beaulieu L, Girouard L, et al. Measurements of intrafraction motion and interfraction and intrafraction rotation of prostate by three-dimensional analysis of daily portal imaging with radiopaque markers. Int J Radiat Oncol Biol Phys. 2004;60:30–39
  23. Murphy MJ. Fiducial-based targeting accuracy for external-beam radiotherapy. Med Phys. 2002;29:334–344
  24. Neustadter D, Djemil T, Mahadevan A, et al. Accuracy of prostate rotation measurement based on 3 implanted fiducial markers. Int J Radiat Oncol Biol Phys. 2008;72:S553
  25. John SS, Zietman AL, Shipley WU, et al. Newer imaging modalities to assist with target localization in the radiation treatment of prostate cancer and possible lymph node metastases. Int J Radiat Oncol Biol Phys. 2008;71:S43–S47
  26. Chen L, Price RA, Nguyen T, et al. Dosimetric evaluation of MRI-based treatment planning for prostate cancer. Phys Med Biol. 2004;49:5157–5170
  27. Chen L, Price RAJ, Wang L, et al. MRI-based treatment planning for radiotherapy: Dosimetric verification for prostate IMRT. Int J Radiat Oncol Biol Phys. 2004;60:636–647
  28. Kerkhof EM, Raaymakers BW, Heide UAVD, et al. Online MRI guidance for healthy tissue sparing in patients with cervical cancer: An IMRT planning study. Radiother Oncol. 2008;88:241–249
  29. Raaymakers BW, Lagendijk JJW, Overweg J, et al. Integrating a 1.5 T MRI scanner with a 6 MV accelerator: proof of concept. Phys Med Biol. 2009;54:N229–N237

 Conflict of interest: D.N. and B.C. are shareholders in Navotek Medical Ltd. D.N., B.C., T.H., and D.C.-Y. are employees of Navotek Medical Ltd.

PII: S0360-3016(09)03335-5

doi: 10.1016/j.ijrobp.2009.09.056

International Journal of Radiation Oncology * Biology * Physics
Volume 77, Issue 4 , Pages 1240-1247 , 15 July 2010